nodes	percent_of_prediction	percent_of_DWPC	metapath
Mianserin—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.0459	0.0712	CbGbCtD
Mianserin—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.0431	0.0669	CbGbCtD
Mianserin—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.0431	0.0669	CbGbCtD
Mianserin—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.039	0.0605	CbGbCtD
Mianserin—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.0327	0.0507	CbGbCtD
Mianserin—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.0296	0.0459	CbGbCtD
Mianserin—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0269	0.0417	CbGbCtD
Mianserin—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0253	0.0393	CbGbCtD
Mianserin—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0253	0.0393	CbGbCtD
Mianserin—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0229	0.0355	CbGbCtD
Mianserin—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0222	0.0344	CbGbCtD
Mianserin—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0208	0.0323	CbGbCtD
Mianserin—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0208	0.0323	CbGbCtD
Mianserin—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0192	0.0297	CbGbCtD
Mianserin—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0189	0.0292	CbGbCtD
Mianserin—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0189	0.0292	CbGbCtD
Mianserin—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0173	0.0269	CbGbCtD
Mianserin—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0163	0.0252	CbGbCtD
Mianserin—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0158	0.0245	CbGbCtD
Mianserin—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0143	0.0222	CbGbCtD
Mianserin—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0143	0.0222	CbGbCtD
Mianserin—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0141	0.0219	CbGbCtD
Mianserin—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0133	0.0206	CbGbCtD
Mianserin—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0133	0.0206	CbGbCtD
Mianserin—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.012	0.0186	CbGbCtD
Mianserin—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.012	0.0186	CbGbCtD
Mianserin—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0103	0.0161	CbGbCtD
Mianserin—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.01	0.0156	CbGbCtD
Mianserin—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00908	0.0141	CbGbCtD
Mianserin—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00908	0.0141	CbGbCtD
Mianserin—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00871	0.0135	CbGbCtD
Mianserin—HRH4—blood—acquired immunodeficiency syndrome	0.00213	0.0281	CbGeAlD
Mianserin—SLC6A3—nerve—acquired immunodeficiency syndrome	0.00211	0.0279	CbGeAlD
Mianserin—HRH4—bone marrow—acquired immunodeficiency syndrome	0.00206	0.0272	CbGeAlD
Mianserin—SLC6A2—nerve—acquired immunodeficiency syndrome	0.0017	0.0225	CbGeAlD
Mianserin—HTR7—nerve—acquired immunodeficiency syndrome	0.00164	0.0217	CbGeAlD
Mianserin—DRD2—nerve—acquired immunodeficiency syndrome	0.00155	0.0205	CbGeAlD
Mianserin—SLC6A4—blood plasma—acquired immunodeficiency syndrome	0.00146	0.0193	CbGeAlD
Mianserin—HTR7—endothelium—acquired immunodeficiency syndrome	0.0014	0.0185	CbGeAlD
Mianserin—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.0013	0.0172	CbGeAlD
Mianserin—HTR7—blood plasma—acquired immunodeficiency syndrome	0.00124	0.0164	CbGeAlD
Mianserin—HRH2—skin of body—acquired immunodeficiency syndrome	0.00117	0.0155	CbGeAlD
Mianserin—HTR1F—nervous system—acquired immunodeficiency syndrome	0.00117	0.0154	CbGeAlD
Mianserin—HTR1F—central nervous system—acquired immunodeficiency syndrome	0.00112	0.0149	CbGeAlD
Mianserin—HTR2A—nerve—acquired immunodeficiency syndrome	0.00102	0.0135	CbGeAlD
Mianserin—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000989	0.0131	CbGeAlD
Mianserin—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.000948	0.0125	CbGeAlD
Mianserin—HRH2—digestive system—acquired immunodeficiency syndrome	0.000938	0.0124	CbGeAlD
Mianserin—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.00091	0.012	CbGeAlD
Mianserin—HRH2—blood—acquired immunodeficiency syndrome	0.000894	0.0118	CbGeAlD
Mianserin—HTR1F—brain—acquired immunodeficiency syndrome	0.000892	0.0118	CbGeAlD
Mianserin—HTR2A—endothelium—acquired immunodeficiency syndrome	0.000871	0.0115	CbGeAlD
Mianserin—DRD3—nervous system—acquired immunodeficiency syndrome	0.000825	0.0109	CbGeAlD
Mianserin—DRD3—central nervous system—acquired immunodeficiency syndrome	0.000794	0.0105	CbGeAlD
Mianserin—HTR6—nervous system—acquired immunodeficiency syndrome	0.000794	0.0105	CbGeAlD
Mianserin—HRH2—lung—acquired immunodeficiency syndrome	0.000784	0.0104	CbGeAlD
Mianserin—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.000774	0.0102	CbGeAlD
Mianserin—HTR6—central nervous system—acquired immunodeficiency syndrome	0.000764	0.0101	CbGeAlD
Mianserin—OPRK1—nervous system—acquired immunodeficiency syndrome	0.000735	0.00971	CbGeAlD
Mianserin—HRH2—nervous system—acquired immunodeficiency syndrome	0.000726	0.00959	CbGeAlD
Mianserin—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000716	0.00946	CbGeAlD
Mianserin—OPRK1—central nervous system—acquired immunodeficiency syndrome	0.000708	0.00935	CbGeAlD
Mianserin—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000705	0.00931	CbGeAlD
Mianserin—HRH2—central nervous system—acquired immunodeficiency syndrome	0.000699	0.00923	CbGeAlD
Mianserin—HTR2B—skin of body—acquired immunodeficiency syndrome	0.000696	0.0092	CbGeAlD
Mianserin—DRD2—retina—acquired immunodeficiency syndrome	0.000642	0.00849	CbGeAlD
Mianserin—DRD3—brain—acquired immunodeficiency syndrome	0.00063	0.00833	CbGeAlD
Mianserin—HTR6—brain—acquired immunodeficiency syndrome	0.000607	0.00802	CbGeAlD
Mianserin—SLC6A3—spinal cord—acquired immunodeficiency syndrome	0.000563	0.00744	CbGeAlD
Mianserin—SLC6A4—digestive system—acquired immunodeficiency syndrome	0.000562	0.00743	CbGeAlD
Mianserin—OPRK1—brain—acquired immunodeficiency syndrome	0.000562	0.00742	CbGeAlD
Mianserin—HTR2B—digestive system—acquired immunodeficiency syndrome	0.000557	0.00736	CbGeAlD
Mianserin—HRH2—brain—acquired immunodeficiency syndrome	0.000555	0.00733	CbGeAlD
Mianserin—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.000544	0.00719	CbGeAlD
Mianserin—HRH2—lymph node—acquired immunodeficiency syndrome	0.000536	0.00708	CbGeAlD
Mianserin—SLC6A4—blood—acquired immunodeficiency syndrome	0.000536	0.00708	CbGeAlD
Mianserin—HTR2B—blood—acquired immunodeficiency syndrome	0.000531	0.00701	CbGeAlD
Mianserin—SLC6A4—spinal cord—acquired immunodeficiency syndrome	0.000516	0.00682	CbGeAlD
Mianserin—SLC6A3—lung—acquired immunodeficiency syndrome	0.000512	0.00677	CbGeAlD
Mianserin—HTR2B—vagina—acquired immunodeficiency syndrome	0.000492	0.0065	CbGeAlD
Mianserin—HTR7—digestive system—acquired immunodeficiency syndrome	0.000477	0.0063	CbGeAlD
Mianserin—SLC6A3—nervous system—acquired immunodeficiency syndrome	0.000474	0.00627	CbGeAlD
Mianserin—SLC6A4—lung—acquired immunodeficiency syndrome	0.00047	0.0062	CbGeAlD
Mianserin—HTR2B—lung—acquired immunodeficiency syndrome	0.000465	0.00615	CbGeAlD
Mianserin—HTR1D—nervous system—acquired immunodeficiency syndrome	0.000463	0.00612	CbGeAlD
Mianserin—HTR2C—nervous system—acquired immunodeficiency syndrome	0.000459	0.00606	CbGeAlD
Mianserin—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.000458	0.00605	CbGeAlD
Mianserin—SLC6A3—central nervous system—acquired immunodeficiency syndrome	0.000457	0.00604	CbGeAlD
Mianserin—CYP2B6—skin of body—acquired immunodeficiency syndrome	0.000456	0.00602	CbGeAlD
Mianserin—HTR7—blood—acquired immunodeficiency syndrome	0.000454	0.006	CbGeAlD
Mianserin—HTR1D—central nervous system—acquired immunodeficiency syndrome	0.000446	0.00589	CbGeAlD
Mianserin—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.000442	0.00583	CbGeAlD
Mianserin—HTR7—spinal cord—acquired immunodeficiency syndrome	0.000438	0.00579	CbGeAlD
Mianserin—SLC6A4—nervous system—acquired immunodeficiency syndrome	0.000435	0.00574	CbGeAlD
Mianserin—HTR2B—nervous system—acquired immunodeficiency syndrome	0.000431	0.00569	CbGeAlD
Mianserin—HTR2A—retina—acquired immunodeficiency syndrome	0.000424	0.0056	CbGeAlD
Mianserin—SLC6A4—central nervous system—acquired immunodeficiency syndrome	0.000419	0.00553	CbGeAlD
Mianserin—ADRA2C—blood—acquired immunodeficiency syndrome	0.000418	0.00552	CbGeAlD
Mianserin—HTR2B—central nervous system—acquired immunodeficiency syndrome	0.000415	0.00548	CbGeAlD
Mianserin—SLC6A2—lung—acquired immunodeficiency syndrome	0.000413	0.00546	CbGeAlD
Mianserin—ADRA2C—spinal cord—acquired immunodeficiency syndrome	0.000402	0.00532	CbGeAlD
Mianserin—HTR7—lung—acquired immunodeficiency syndrome	0.000398	0.00526	CbGeAlD
Mianserin—ADRA2C—vagina—acquired immunodeficiency syndrome	0.000387	0.00512	CbGeAlD
Mianserin—HTR1A—nervous system—acquired immunodeficiency syndrome	0.000386	0.0051	CbGeAlD
Mianserin—Oedema—Zidovudine—acquired immunodeficiency syndrome	0.000385	0.0019	CcSEcCtD
Mianserin—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000383	0.00189	CcSEcCtD
Mianserin—Anaemia—Efavirenz—acquired immunodeficiency syndrome	0.000383	0.00189	CcSEcCtD
Mianserin—SLC6A2—nervous system—acquired immunodeficiency syndrome	0.000383	0.00506	CbGeAlD
Mianserin—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000382	0.00188	CcSEcCtD
Mianserin—Angiopathy—Ritonavir—acquired immunodeficiency syndrome	0.000382	0.00188	CcSEcCtD
Mianserin—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.000382	0.00188	CcSEcCtD
Mianserin—Agitation—Efavirenz—acquired immunodeficiency syndrome	0.000381	0.00188	CcSEcCtD
Mianserin—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.00038	0.00503	CbGeAlD
Mianserin—Connective tissue disorder—Lamivudine—acquired immunodeficiency syndrome	0.00038	0.00187	CcSEcCtD
Mianserin—Mediastinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00038	0.00187	CcSEcCtD
Mianserin—Eye disorder—Saquinavir—acquired immunodeficiency syndrome	0.000379	0.00187	CcSEcCtD
Mianserin—Constipation—Stavudine—acquired immunodeficiency syndrome	0.000379	0.00186	CcSEcCtD
Mianserin—Shock—Zidovudine—acquired immunodeficiency syndrome	0.000379	0.00186	CcSEcCtD
Mianserin—Tinnitus—Saquinavir—acquired immunodeficiency syndrome	0.000378	0.00186	CcSEcCtD
Mianserin—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.000378	0.00186	CcSEcCtD
Mianserin—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.000377	0.00186	CcSEcCtD
Mianserin—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.000377	0.00186	CcSEcCtD
Mianserin—DRD2—lung—acquired immunodeficiency syndrome	0.000377	0.00498	CbGeAlD
Mianserin—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000377	0.00185	CcSEcCtD
Mianserin—Cardiac disorder—Saquinavir—acquired immunodeficiency syndrome	0.000376	0.00185	CcSEcCtD
Mianserin—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.000376	0.00185	CcSEcCtD
Mianserin—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000374	0.00184	CcSEcCtD
Mianserin—Myalgia—Indinavir—acquired immunodeficiency syndrome	0.000373	0.00184	CcSEcCtD
Mianserin—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.000373	0.00184	CcSEcCtD
Mianserin—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.000372	0.00183	CcSEcCtD
Mianserin—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.000372	0.00491	CbGeAlD
Mianserin—Syncope—Efavirenz—acquired immunodeficiency syndrome	0.000372	0.00183	CcSEcCtD
Mianserin—Tremor—Delavirdine—acquired immunodeficiency syndrome	0.000371	0.00183	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.000371	0.00183	CcSEcCtD
Mianserin—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	0.000369	0.00488	CbGeAlD
Mianserin—HTR7—nervous system—acquired immunodeficiency syndrome	0.000369	0.00487	CbGeAlD
Mianserin—Mental disorder—Ritonavir—acquired immunodeficiency syndrome	0.000369	0.00182	CcSEcCtD
Mianserin—SLC6A2—central nervous system—acquired immunodeficiency syndrome	0.000369	0.00487	CbGeAlD
Mianserin—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.000368	0.00181	CcSEcCtD
Mianserin—Anaemia—Delavirdine—acquired immunodeficiency syndrome	0.000366	0.0018	CcSEcCtD
Mianserin—ADRA2C—lung—acquired immunodeficiency syndrome	0.000366	0.00484	CbGeAlD
Mianserin—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.000366	0.0018	CcSEcCtD
Mianserin—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000366	0.0018	CcSEcCtD
Mianserin—Mediastinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000365	0.0018	CcSEcCtD
Mianserin—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.000365	0.0018	CcSEcCtD
Mianserin—CYP2B6—digestive system—acquired immunodeficiency syndrome	0.000365	0.00482	CbGeAlD
Mianserin—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.000364	0.00179	CcSEcCtD
Mianserin—Loss of consciousness—Efavirenz—acquired immunodeficiency syndrome	0.000364	0.00179	CcSEcCtD
Mianserin—SLC6A3—brain—acquired immunodeficiency syndrome	0.000363	0.00479	CbGeAlD
Mianserin—CYP1A2—blood—acquired immunodeficiency syndrome	0.000362	0.00479	CbGeAlD
Mianserin—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000361	0.00178	CcSEcCtD
Mianserin—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.000359	0.00177	CcSEcCtD
Mianserin—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000359	0.00177	CcSEcCtD
Mianserin—Oedema—Indinavir—acquired immunodeficiency syndrome	0.000358	0.00176	CcSEcCtD
Mianserin—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.000358	0.00176	CcSEcCtD
Mianserin—HRH1—digestive system—acquired immunodeficiency syndrome	0.000356	0.00471	CbGeAlD
Mianserin—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.000356	0.00175	CcSEcCtD
Mianserin—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.000356	0.00175	CcSEcCtD
Mianserin—HTR7—central nervous system—acquired immunodeficiency syndrome	0.000355	0.00469	CbGeAlD
Mianserin—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	0.000355	0.00175	CcSEcCtD
Mianserin—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.000355	0.00175	CcSEcCtD
Mianserin—HTR1D—brain—acquired immunodeficiency syndrome	0.000354	0.00468	CbGeAlD
Mianserin—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.000353	0.00174	CcSEcCtD
Mianserin—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.000353	0.00174	CcSEcCtD
Mianserin—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000353	0.00174	CcSEcCtD
Mianserin—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000352	0.00174	CcSEcCtD
Mianserin—Shock—Indinavir—acquired immunodeficiency syndrome	0.000352	0.00173	CcSEcCtD
Mianserin—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000351	0.00173	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000351	0.00173	CcSEcCtD
Mianserin—HTR2C—brain—acquired immunodeficiency syndrome	0.000351	0.00463	CbGeAlD
Mianserin—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00035	0.00173	CcSEcCtD
Mianserin—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.00035	0.00173	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.00035	0.00173	CcSEcCtD
Mianserin—DRD2—nervous system—acquired immunodeficiency syndrome	0.000349	0.00461	CbGeAlD
Mianserin—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000348	0.00172	CcSEcCtD
Mianserin—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.000348	0.00172	CcSEcCtD
Mianserin—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000348	0.00171	CcSEcCtD
Mianserin—CYP2B6—blood—acquired immunodeficiency syndrome	0.000347	0.00459	CbGeAlD
Mianserin—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000346	0.0017	CcSEcCtD
Mianserin—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000345	0.0017	CcSEcCtD
Mianserin—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000343	0.00169	CcSEcCtD
Mianserin—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.000342	0.00169	CcSEcCtD
Mianserin—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000342	0.00168	CcSEcCtD
Mianserin—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000341	0.00168	CcSEcCtD
Mianserin—ADRA2C—nervous system—acquired immunodeficiency syndrome	0.000339	0.00448	CbGeAlD
Mianserin—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000339	0.00167	CcSEcCtD
Mianserin—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000337	0.00166	CcSEcCtD
Mianserin—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000337	0.00166	CcSEcCtD
Mianserin—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000337	0.00166	CcSEcCtD
Mianserin—DRD2—central nervous system—acquired immunodeficiency syndrome	0.000336	0.00444	CbGeAlD
Mianserin—ADRA2A—blood—acquired immunodeficiency syndrome	0.000333	0.0044	CbGeAlD
Mianserin—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000333	0.00164	CcSEcCtD
Mianserin—SLC6A4—brain—acquired immunodeficiency syndrome	0.000332	0.00439	CbGeAlD
Mianserin—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000332	0.00164	CcSEcCtD
Mianserin—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000332	0.00163	CcSEcCtD
Mianserin—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000332	0.00163	CcSEcCtD
Mianserin—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000331	0.00163	CcSEcCtD
Mianserin—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000331	0.00163	CcSEcCtD
Mianserin—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.00033	0.00163	CcSEcCtD
Mianserin—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.00033	0.00163	CcSEcCtD
Mianserin—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000329	0.00162	CcSEcCtD
Mianserin—HTR2B—brain—acquired immunodeficiency syndrome	0.000329	0.00435	CbGeAlD
Mianserin—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000329	0.00162	CcSEcCtD
Mianserin—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000329	0.00162	CcSEcCtD
Mianserin—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000329	0.00162	CcSEcCtD
Mianserin—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000328	0.00162	CcSEcCtD
Mianserin—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000328	0.00162	CcSEcCtD
Mianserin—ADRA2C—central nervous system—acquired immunodeficiency syndrome	0.000326	0.00431	CbGeAlD
Mianserin—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000326	0.00161	CcSEcCtD
Mianserin—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000326	0.00161	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000326	0.00161	CcSEcCtD
Mianserin—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000324	0.0016	CcSEcCtD
Mianserin—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000324	0.0016	CcSEcCtD
Mianserin—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000324	0.00159	CcSEcCtD
Mianserin—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000322	0.00159	CcSEcCtD
Mianserin—CYP2B6—vagina—acquired immunodeficiency syndrome	0.000322	0.00426	CbGeAlD
Mianserin—Rash—Didanosine—acquired immunodeficiency syndrome	0.000322	0.00158	CcSEcCtD
Mianserin—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000321	0.00158	CcSEcCtD
Mianserin—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000321	0.00158	CcSEcCtD
Mianserin—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.000321	0.00424	CbGeAlD
Mianserin—Headache—Didanosine—acquired immunodeficiency syndrome	0.000319	0.00157	CcSEcCtD
Mianserin—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000319	0.00157	CcSEcCtD
Mianserin—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000318	0.00157	CcSEcCtD
Mianserin—HTR2B—lymph node—acquired immunodeficiency syndrome	0.000318	0.0042	CbGeAlD
Mianserin—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000318	0.00157	CcSEcCtD
Mianserin—CYP1A2—lung—acquired immunodeficiency syndrome	0.000318	0.0042	CbGeAlD
Mianserin—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000318	0.00156	CcSEcCtD
Mianserin—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000318	0.00156	CcSEcCtD
Mianserin—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000317	0.00156	CcSEcCtD
Mianserin—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000317	0.00156	CcSEcCtD
Mianserin—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000317	0.00156	CcSEcCtD
Mianserin—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000317	0.00156	CcSEcCtD
Mianserin—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000316	0.00156	CcSEcCtD
Mianserin—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000316	0.00156	CcSEcCtD
Mianserin—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000316	0.00156	CcSEcCtD
Mianserin—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000315	0.00155	CcSEcCtD
Mianserin—HRH1—vagina—acquired immunodeficiency syndrome	0.000315	0.00416	CbGeAlD
Mianserin—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000314	0.00155	CcSEcCtD
Mianserin—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000314	0.00155	CcSEcCtD
Mianserin—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000313	0.00154	CcSEcCtD
Mianserin—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000313	0.00154	CcSEcCtD
Mianserin—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000312	0.00154	CcSEcCtD
Mianserin—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000312	0.00154	CcSEcCtD
Mianserin—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000311	0.00153	CcSEcCtD
Mianserin—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.00031	0.00153	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.00031	0.00153	CcSEcCtD
Mianserin—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000309	0.00152	CcSEcCtD
Mianserin—ADRA2A—vagina—acquired immunodeficiency syndrome	0.000309	0.00408	CbGeAlD
Mianserin—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000309	0.00152	CcSEcCtD
Mianserin—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000309	0.00152	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000308	0.00152	CcSEcCtD
Mianserin—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000306	0.00151	CcSEcCtD
Mianserin—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000306	0.00151	CcSEcCtD
Mianserin—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000305	0.0015	CcSEcCtD
Mianserin—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000305	0.0015	CcSEcCtD
Mianserin—CYP2B6—lung—acquired immunodeficiency syndrome	0.000305	0.00402	CbGeAlD
Mianserin—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000304	0.0015	CcSEcCtD
Mianserin—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000302	0.00149	CcSEcCtD
Mianserin—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000302	0.00149	CcSEcCtD
Mianserin—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000302	0.00149	CcSEcCtD
Mianserin—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000302	0.00149	CcSEcCtD
Mianserin—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000301	0.00148	CcSEcCtD
Mianserin—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000301	0.00148	CcSEcCtD
Mianserin—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.0003	0.00148	CcSEcCtD
Mianserin—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.0003	0.00148	CcSEcCtD
Mianserin—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000299	0.00147	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000298	0.00147	CcSEcCtD
Mianserin—HTR2A—digestive system—acquired immunodeficiency syndrome	0.000297	0.00393	CbGeAlD
Mianserin—HRH1—lung—acquired immunodeficiency syndrome	0.000297	0.00393	CbGeAlD
Mianserin—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000296	0.00146	CcSEcCtD
Mianserin—HTR1A—brain—acquired immunodeficiency syndrome	0.000295	0.0039	CbGeAlD
Mianserin—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000295	0.00145	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000295	0.00145	CcSEcCtD
Mianserin—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000294	0.00145	CcSEcCtD
Mianserin—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000294	0.00145	CcSEcCtD
Mianserin—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000294	0.00145	CcSEcCtD
Mianserin—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000293	0.00144	CcSEcCtD
Mianserin—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000293	0.00144	CcSEcCtD
Mianserin—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000293	0.00144	CcSEcCtD
Mianserin—SLC6A2—brain—acquired immunodeficiency syndrome	0.000293	0.00387	CbGeAlD
Mianserin—ADRA2A—lung—acquired immunodeficiency syndrome	0.000292	0.00386	CbGeAlD
Mianserin—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000292	0.00144	CcSEcCtD
Mianserin—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000292	0.00144	CcSEcCtD
Mianserin—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000292	0.00144	CcSEcCtD
Mianserin—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000292	0.00144	CcSEcCtD
Mianserin—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000291	0.00143	CcSEcCtD
Mianserin—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000291	0.00143	CcSEcCtD
Mianserin—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.00029	0.00143	CcSEcCtD
Mianserin—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000289	0.00142	CcSEcCtD
Mianserin—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000289	0.00142	CcSEcCtD
Mianserin—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000289	0.00142	CcSEcCtD
Mianserin—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000288	0.00142	CcSEcCtD
Mianserin—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000288	0.00142	CcSEcCtD
Mianserin—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000288	0.00142	CcSEcCtD
Mianserin—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000287	0.00141	CcSEcCtD
Mianserin—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000287	0.00141	CcSEcCtD
Mianserin—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000287	0.00141	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000285	0.0014	CcSEcCtD
Mianserin—HTR2A—blood—acquired immunodeficiency syndrome	0.000283	0.00374	CbGeAlD
Mianserin—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000283	0.0014	CcSEcCtD
Mianserin—SLC6A2—lymph node—acquired immunodeficiency syndrome	0.000283	0.00374	CbGeAlD
Mianserin—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000282	0.00139	CcSEcCtD
Mianserin—CYP2B6—nervous system—acquired immunodeficiency syndrome	0.000282	0.00373	CbGeAlD
Mianserin—HTR7—brain—acquired immunodeficiency syndrome	0.000282	0.00373	CbGeAlD
Mianserin—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000282	0.00139	CcSEcCtD
Mianserin—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.00028	0.00138	CcSEcCtD
Mianserin—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00028	0.00138	CcSEcCtD
Mianserin—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00028	0.00138	CcSEcCtD
Mianserin—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.00028	0.00138	CcSEcCtD
Mianserin—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00028	0.00138	CcSEcCtD
Mianserin—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000279	0.00138	CcSEcCtD
Mianserin—Rash—Stavudine—acquired immunodeficiency syndrome	0.000279	0.00137	CcSEcCtD
Mianserin—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000279	0.00137	CcSEcCtD
Mianserin—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000279	0.00137	CcSEcCtD
Mianserin—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000279	0.00137	CcSEcCtD
Mianserin—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000278	0.00137	CcSEcCtD
Mianserin—Headache—Stavudine—acquired immunodeficiency syndrome	0.000277	0.00137	CcSEcCtD
Mianserin—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000277	0.00136	CcSEcCtD
Mianserin—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000277	0.00136	CcSEcCtD
Mianserin—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000276	0.00136	CcSEcCtD
Mianserin—HRH1—nervous system—acquired immunodeficiency syndrome	0.000275	0.00364	CbGeAlD
Mianserin—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000275	0.00364	CbGeAlD
Mianserin—Rash—Abacavir—acquired immunodeficiency syndrome	0.000275	0.00135	CcSEcCtD
Mianserin—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000275	0.00135	CcSEcCtD
Mianserin—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000275	0.00135	CcSEcCtD
Mianserin—Headache—Abacavir—acquired immunodeficiency syndrome	0.000273	0.00135	CcSEcCtD
Mianserin—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.000273	0.00361	CbGeAlD
Mianserin—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000273	0.00134	CcSEcCtD
Mianserin—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000272	0.00134	CcSEcCtD
Mianserin—CYP2B6—central nervous system—acquired immunodeficiency syndrome	0.000272	0.00359	CbGeAlD
Mianserin—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000271	0.00358	CbGeAlD
Mianserin—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.000271	0.00358	CbGeAlD
Mianserin—Shock—Lamivudine—acquired immunodeficiency syndrome	0.00027	0.00133	CcSEcCtD
Mianserin—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000269	0.00133	CcSEcCtD
Mianserin—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000269	0.00133	CcSEcCtD
Mianserin—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000269	0.00132	CcSEcCtD
Mianserin—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000269	0.00132	CcSEcCtD
Mianserin—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000267	0.00131	CcSEcCtD
Mianserin—DRD2—brain—acquired immunodeficiency syndrome	0.000267	0.00352	CbGeAlD
Mianserin—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000267	0.00131	CcSEcCtD
Mianserin—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000266	0.00131	CcSEcCtD
Mianserin—HRH1—central nervous system—acquired immunodeficiency syndrome	0.000265	0.0035	CbGeAlD
Mianserin—HTR2A—vagina—acquired immunodeficiency syndrome	0.000263	0.00347	CbGeAlD
Mianserin—CYP3A4—blood—acquired immunodeficiency syndrome	0.000262	0.00347	CbGeAlD
Mianserin—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000262	0.00129	CcSEcCtD
Mianserin—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.000261	0.00344	CbGeAlD
Mianserin—ADRA2C—brain—acquired immunodeficiency syndrome	0.000259	0.00342	CbGeAlD
Mianserin—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000259	0.00127	CcSEcCtD
Mianserin—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000258	0.00127	CcSEcCtD
Mianserin—CYP2D6—blood—acquired immunodeficiency syndrome	0.000258	0.00341	CbGeAlD
Mianserin—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000258	0.00127	CcSEcCtD
Mianserin—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000257	0.00126	CcSEcCtD
Mianserin—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000257	0.00126	CcSEcCtD
Mianserin—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000256	0.00126	CcSEcCtD
Mianserin—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000256	0.00126	CcSEcCtD
Mianserin—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000254	0.00125	CcSEcCtD
Mianserin—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000253	0.00125	CcSEcCtD
Mianserin—ADRA2C—lymph node—acquired immunodeficiency syndrome	0.00025	0.00331	CbGeAlD
Mianserin—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00025	0.00123	CcSEcCtD
Mianserin—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000249	0.00122	CcSEcCtD
Mianserin—HTR2A—lung—acquired immunodeficiency syndrome	0.000248	0.00328	CbGeAlD
Mianserin—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000248	0.00122	CcSEcCtD
Mianserin—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000247	0.00121	CcSEcCtD
Mianserin—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000247	0.00121	CcSEcCtD
Mianserin—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000246	0.00121	CcSEcCtD
Mianserin—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000244	0.0012	CcSEcCtD
Mianserin—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000243	0.00119	CcSEcCtD
Mianserin—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000243	0.00119	CcSEcCtD
Mianserin—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000242	0.00119	CcSEcCtD
Mianserin—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000241	0.00119	CcSEcCtD
Mianserin—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000239	0.00118	CcSEcCtD
Mianserin—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000237	0.00117	CcSEcCtD
Mianserin—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000237	0.00117	CcSEcCtD
Mianserin—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000237	0.00117	CcSEcCtD
Mianserin—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000237	0.00117	CcSEcCtD
Mianserin—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000235	0.00116	CcSEcCtD
Mianserin—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000232	0.00114	CcSEcCtD
Mianserin—HTR2A—nervous system—acquired immunodeficiency syndrome	0.00023	0.00304	CbGeAlD
Mianserin—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000229	0.00113	CcSEcCtD
Mianserin—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000226	0.00111	CcSEcCtD
Mianserin—Rash—Indinavir—acquired immunodeficiency syndrome	0.000226	0.00111	CcSEcCtD
Mianserin—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000225	0.00111	CcSEcCtD
Mianserin—Headache—Indinavir—acquired immunodeficiency syndrome	0.000224	0.0011	CcSEcCtD
Mianserin—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000224	0.0011	CcSEcCtD
Mianserin—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.000222	0.00293	CbGeAlD
Mianserin—CYP2B6—brain—acquired immunodeficiency syndrome	0.000216	0.00285	CbGeAlD
Mianserin—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000215	0.00106	CcSEcCtD
Mianserin—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000214	0.00105	CcSEcCtD
Mianserin—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000213	0.00105	CcSEcCtD
Mianserin—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000213	0.00105	CcSEcCtD
Mianserin—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000213	0.00281	CbGeAlD
Mianserin—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000212	0.00104	CcSEcCtD
Mianserin—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000212	0.00104	CcSEcCtD
Mianserin—HRH1—brain—acquired immunodeficiency syndrome	0.000211	0.00278	CbGeAlD
Mianserin—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.00021	0.00277	CbGeAlD
Mianserin—ADRA2A—brain—acquired immunodeficiency syndrome	0.000207	0.00273	CbGeAlD
Mianserin—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000207	0.00102	CcSEcCtD
Mianserin—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000205	0.00271	CbGeAlD
Mianserin—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000204	0.001	CcSEcCtD
Mianserin—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000204	0.001	CcSEcCtD
Mianserin—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000204	0.001	CcSEcCtD
Mianserin—HRH1—lymph node—acquired immunodeficiency syndrome	0.000203	0.00269	CbGeAlD
Mianserin—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000203	0.000998	CcSEcCtD
Mianserin—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000202	0.00267	CbGeAlD
Mianserin—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.0002	0.00264	CbGeAlD
Mianserin—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000198	0.000974	CcSEcCtD
Mianserin—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000197	0.000971	CcSEcCtD
Mianserin—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000194	0.000957	CcSEcCtD
Mianserin—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.000938	CcSEcCtD
Mianserin—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000189	0.000929	CcSEcCtD
Mianserin—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000188	0.000928	CcSEcCtD
Mianserin—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000187	0.000923	CcSEcCtD
Mianserin—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.000895	CcSEcCtD
Mianserin—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000182	0.000894	CcSEcCtD
Mianserin—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000181	0.000893	CcSEcCtD
Mianserin—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00018	0.000888	CcSEcCtD
Mianserin—HTR2A—brain—acquired immunodeficiency syndrome	0.000176	0.00232	CbGeAlD
Mianserin—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000173	0.000853	CcSEcCtD
Mianserin—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000173	0.000852	CcSEcCtD
Mianserin—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000172	0.000848	CcSEcCtD
Mianserin—CYP2D6—brain—acquired immunodeficiency syndrome	0.00016	0.00212	CbGeAlD
Mianserin—HTR6—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.5e-05	0.000326	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.5e-05	0.000326	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.5e-05	0.000326	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.49e-05	0.000325	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.48e-05	0.000324	CbGpPWpGaD
Mianserin—HTR1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.47e-05	0.000322	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.47e-05	0.000322	CbGpPWpGaD
Mianserin—HTR2C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.46e-05	0.000321	CbGpPWpGaD
Mianserin—HTR1F—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.45e-05	0.000319	CbGpPWpGaD
Mianserin—HTR1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.43e-05	0.000317	CbGpPWpGaD
Mianserin—ADRA2C—Hemostasis—ALB—acquired immunodeficiency syndrome	2.43e-05	0.000317	CbGpPWpGaD
Mianserin—HTR2C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.42e-05	0.000316	CbGpPWpGaD
Mianserin—ADRA2C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.39e-05	0.000312	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.39e-05	0.000311	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.39e-05	0.000311	CbGpPWpGaD
Mianserin—SLC6A3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.38e-05	0.00031	CbGpPWpGaD
Mianserin—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.36e-05	0.000308	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.36e-05	0.000307	CbGpPWpGaD
Mianserin—ADRA2C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.36e-05	0.000307	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.35e-05	0.000307	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.35e-05	0.000307	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.35e-05	0.000307	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.35e-05	0.000307	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.35e-05	0.000307	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.34e-05	0.000305	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.34e-05	0.000305	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.34e-05	0.000304	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.32e-05	0.000303	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.32e-05	0.000302	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.32e-05	0.000302	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.32e-05	0.000302	CbGpPWpGaD
Mianserin—ADRA2B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.31e-05	0.000301	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.3e-05	0.0003	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.29e-05	0.000299	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.29e-05	0.000298	CbGpPWpGaD
Mianserin—HRH2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.27e-05	0.000295	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.24e-05	0.000293	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.23e-05	0.000291	CbGpPWpGaD
Mianserin—HTR1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.23e-05	0.00029	CbGpPWpGaD
Mianserin—HTR2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.22e-05	0.000289	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.21e-05	0.000288	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.2e-05	0.000287	CbGpPWpGaD
Mianserin—DRD2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	2.2e-05	0.000287	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.17e-05	0.000283	CbGpPWpGaD
Mianserin—DRD2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.17e-05	0.000283	CbGpPWpGaD
Mianserin—ADRA2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.15e-05	0.000281	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	2.15e-05	0.000281	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.15e-05	0.00028	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.15e-05	0.00028	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.14e-05	0.000279	CbGpPWpGaD
Mianserin—DRD2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.14e-05	0.000279	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.14e-05	0.000278	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.13e-05	0.000278	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.13e-05	0.000277	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.12e-05	0.000277	CbGpPWpGaD
Mianserin—ADRA2B—Hemostasis—IL2—acquired immunodeficiency syndrome	2.11e-05	0.000275	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.1e-05	0.000274	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.1e-05	0.000274	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.1e-05	0.000274	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.09e-05	0.000273	CbGpPWpGaD
Mianserin—HRH2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.06e-05	0.000268	CbGpPWpGaD
Mianserin—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.05e-05	0.000267	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.05e-05	0.000267	CbGpPWpGaD
Mianserin—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.05e-05	0.000267	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.04e-05	0.000266	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.02e-05	0.000264	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.01e-05	0.000262	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2e-05	0.000261	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2e-05	0.000261	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.98e-05	0.000259	CbGpPWpGaD
Mianserin—ADRA2A—Hemostasis—ALB—acquired immunodeficiency syndrome	1.97e-05	0.000257	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.97e-05	0.000257	CbGpPWpGaD
Mianserin—ADRA2C—Hemostasis—IL2—acquired immunodeficiency syndrome	1.97e-05	0.000257	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.96e-05	0.000255	CbGpPWpGaD
Mianserin—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.95e-05	0.000255	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	1.95e-05	0.000255	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.94e-05	0.000253	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.94e-05	0.000253	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.94e-05	0.000253	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.93e-05	0.000252	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.92e-05	0.000251	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.92e-05	0.00025	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.92e-05	0.00025	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.91e-05	0.000249	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.91e-05	0.000249	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.91e-05	0.000248	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.85e-05	0.000242	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.84e-05	0.00024	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.82e-05	0.000237	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.81e-05	0.000235	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.81e-05	0.000235	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.8e-05	0.000235	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.79e-05	0.000234	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.79e-05	0.000234	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.79e-05	0.000233	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.79e-05	0.000233	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.78e-05	0.000232	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.78e-05	0.000231	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.77e-05	0.000231	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.77e-05	0.00023	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.76e-05	0.00023	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.76e-05	0.00023	CbGpPWpGaD
Mianserin—OPRK1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.76e-05	0.00023	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.76e-05	0.00023	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.75e-05	0.000228	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.75e-05	0.000228	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.75e-05	0.000228	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.74e-05	0.000227	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.74e-05	0.000227	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.74e-05	0.000227	CbGpPWpGaD
Mianserin—HTR6—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.74e-05	0.000227	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.74e-05	0.000227	CbGpPWpGaD
Mianserin—HTR7—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.74e-05	0.000226	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.73e-05	0.000226	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.73e-05	0.000226	CbGpPWpGaD
Mianserin—HTR1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.72e-05	0.000225	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.69e-05	0.00022	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.69e-05	0.00022	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	1.66e-05	0.000217	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.64e-05	0.000213	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.63e-05	0.000213	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.63e-05	0.000212	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.61e-05	0.00021	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.61e-05	0.00021	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.61e-05	0.00021	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.61e-05	0.00021	CbGpPWpGaD
Mianserin—OPRK1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.6e-05	0.000209	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.6e-05	0.000209	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.6e-05	0.000209	CbGpPWpGaD
Mianserin—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	1.6e-05	0.000209	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.6e-05	0.000208	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.59e-05	0.000207	CbGpPWpGaD
Mianserin—HTR2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.59e-05	0.000207	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.58e-05	0.000206	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.58e-05	0.000206	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.57e-05	0.000204	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.57e-05	0.000204	CbGpPWpGaD
Mianserin—HRH4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.56e-05	0.000203	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.53e-05	0.000199	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.53e-05	0.000199	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.52e-05	0.000198	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.51e-05	0.000196	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.51e-05	0.000196	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.5e-05	0.000196	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.5e-05	0.000196	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.5e-05	0.000195	CbGpPWpGaD
Mianserin—DRD3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.48e-05	0.000192	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.47e-05	0.000192	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.46e-05	0.00019	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.45e-05	0.000189	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.44e-05	0.000188	CbGpPWpGaD
Mianserin—HTR1F—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.44e-05	0.000188	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.37e-05	0.000179	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.37e-05	0.000179	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.37e-05	0.000179	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.37e-05	0.000179	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.35e-05	0.000176	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.34e-05	0.000175	CbGpPWpGaD
Mianserin—ADRA2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.33e-05	0.000174	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.33e-05	0.000173	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.32e-05	0.000172	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.31e-05	0.00017	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.3e-05	0.000169	CbGpPWpGaD
Mianserin—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.29e-05	0.000168	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.28e-05	0.000167	CbGpPWpGaD
Mianserin—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.28e-05	0.000167	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.26e-05	0.000165	CbGpPWpGaD
Mianserin—ADRA2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.24e-05	0.000162	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.24e-05	0.000161	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.22e-05	0.000158	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.21e-05	0.000158	CbGpPWpGaD
Mianserin—HRH2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.21e-05	0.000158	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.19e-05	0.000156	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.19e-05	0.000155	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.17e-05	0.000152	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.16e-05	0.000152	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.16e-05	0.000152	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.16e-05	0.000151	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.15e-05	0.000149	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.15e-05	0.000149	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.14e-05	0.000149	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.13e-05	0.000147	CbGpPWpGaD
Mianserin—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.13e-05	0.000147	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.13e-05	0.000147	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.13e-05	0.000147	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.11e-05	0.000145	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.11e-05	0.000145	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.05e-05	0.000137	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.04e-05	0.000136	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.03e-05	0.000135	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.03e-05	0.000134	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.03e-05	0.000134	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.03e-05	0.000134	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.01e-05	0.000132	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.01e-05	0.000132	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.01e-05	0.000131	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	9.92e-06	0.000129	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—ALB—acquired immunodeficiency syndrome	9.85e-06	0.000128	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.46e-06	0.000123	CbGpPWpGaD
Mianserin—OPRK1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.41e-06	0.000123	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.39e-06	0.000122	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.32e-06	0.000122	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.31e-06	0.000121	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.28e-06	0.000121	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.27e-06	0.000121	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.25e-06	0.000121	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	9.21e-06	0.00012	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.21e-06	0.00012	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.18e-06	0.00012	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.51e-06	0.000111	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.5e-06	0.000111	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.47e-06	0.00011	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	8e-06	0.000104	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.92e-06	0.000103	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.88e-06	0.000103	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—ALB—acquired immunodeficiency syndrome	7.5e-06	9.78e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.15e-06	9.32e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.15e-06	9.32e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.11e-06	9.27e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.9e-06	9e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.87e-06	8.95e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.87e-06	8.95e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.83e-06	8.91e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.68e-06	8.71e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.64e-06	8.66e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.06e-06	7.9e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.03e-06	7.86e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.96e-06	7.77e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.95e-06	7.76e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.93e-06	7.73e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.92e-06	7.72e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.56e-06	7.25e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.48e-06	7.14e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.47e-06	7.14e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.44e-06	7.09e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.42e-06	7.07e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.4e-06	7.04e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	5.21e-06	6.8e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5e-06	6.52e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.65e-06	6.07e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	4.42e-06	5.76e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.2e-06	5.48e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.06e-06	5.29e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.04e-06	5.26e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.93e-06	5.12e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.56e-06	4.64e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.5e-06	4.57e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.5e-06	4.56e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	3.41e-06	4.44e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.19e-06	4.16e-05	CbGpPWpGaD
